{"title":"Adults with low opsonic natural antibody levels against <i>Streptococcus pneumoniae</i> show enhanced response to PPSV23 vaccination.","authors":"Sravani Dharmavaram, Geetha Nagaraj, Sundaresan Natesan, Manjula Subbanna, Ravikumar Kadahalli Lingegowda","doi":"10.1080/15321819.2024.2430344","DOIUrl":"10.1080/15321819.2024.2430344","url":null,"abstract":"<p><strong>Background: </strong>Pneumococcal diseases pose a significant public health concern globally, particularly among young children and the elderly. Vaccination plays a crucial role in their prevention. This study evaluated the functional immune responses to Pneumococcal polysaccharide vaccine serotypes in healthy Indian adults before and after administering a single dose of PPSV23 immunization.</p><p><strong>Methods: </strong>A total of 125 healthy participants aged 18-65 received the PPSV23 vaccine, and their pre- and post-immunization sera were analyzed by MOPA. Opsonic Index, Geometric mean OPA titers and fold increase for each serotype was calculated.</p><p><strong>Results: </strong>The highest baseline OPA GMTs were observed for serotypes 33F,17F,9N,20, and 6B. The lowest OPA GMTs were noted against types 1 and 12F. OPA GMTs post-vaccination increased significantly for all serotypes, with geometric mean fold rise (GMFR) ranging from 4.3 to 267.5. Participants with low pre-immunization OPA titers (<8 & <64) showed significant increases in OI fold raise across all tested serotypes post-vaccination. This robust immune response was consistent across serotypes, indicating highly effective seroconversion in individuals with low baseline antibody levels.</p><p><strong>Conclusion: </strong>The PPSV23 vaccine elicits a strong immunogenic response in individuals with low pre-immunization OPA titers, achieving substantial increases in opsonic index fold raise across various serotypes.</p>","PeriodicalId":15990,"journal":{"name":"Journal of immunoassay & immunochemistry","volume":" ","pages":"29-48"},"PeriodicalIF":0.0,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Emerging therapies and innovations in vitiligo management: a comprehensive review.","authors":"Manjusha Bhange, Sachin Kothawade, Darshan Telange, Vijaya Padwal","doi":"10.1080/15321819.2024.2412528","DOIUrl":"10.1080/15321819.2024.2412528","url":null,"abstract":"<p><p>Vitiligo is a common skin disorder where melanocytes, the cells that produce skin pigment, are destroyed by the immune system, leading to white patches on the skin and mucous membranes. This condition affects 0.4% to 2.0% of the global population, with a higher prevalence in females and often beginning in childhood. In India, about 1% of the population is affected, particularly in northern regions, with a higher incidence in females and links to other autoimmune diseases. This review examines recent progress in understanding vitiligo and its treatment. It focuses on the genetic, autoimmune, and environmental factors involved in the disease and highlights new therapies, such as targeted molecular treatments and advanced repigmentation methods. Current research shows that oxidative stress and genetic predispositions contribute to the autoimmune destruction of melanocytes. Novel drug delivery systems, including liposomes, nanoemulsions, and nanostructured lipid carriers, have improved treatment effectiveness. Clinical trials are exploring new treatments like Ruxolitinib cream and melanocyte transplantation, while teledermatology is becoming useful for managing patients. Vitiligo also poses a significant economic burden due to its impact on patients' quality of life. Continued research is essential to develop better, more accessible treatments and reduce the economic impact of vitiligo.</p>","PeriodicalId":15990,"journal":{"name":"Journal of immunoassay & immunochemistry","volume":" ","pages":"1-28"},"PeriodicalIF":0.0,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vincenzo Brescia, Roberto Lovero, Antonietta Fontana, Francesca Di Serio, Marica Colella, Vincenza Carbone, Marika Giliberti, Maria Grazia Perrone, Antonio Scilimati, Raffaele Palmirotta
{"title":"Analytical interference of Burosumab therapy on intact fibroblast growth factor 23 (iFGF23) measurements using an immunoassay: preliminary evaluation.","authors":"Vincenzo Brescia, Roberto Lovero, Antonietta Fontana, Francesca Di Serio, Marica Colella, Vincenza Carbone, Marika Giliberti, Maria Grazia Perrone, Antonio Scilimati, Raffaele Palmirotta","doi":"10.1080/15321819.2024.2422098","DOIUrl":"10.1080/15321819.2024.2422098","url":null,"abstract":"<p><p>Our study evaluated the possible interference of Burosumab (human recombinant monoclonal antibody directed against N-terminal domain of FGF23) on the immunoassay of intact FGF23 (iFGF23) with the Liaison XL. The analytical method uses three different antibodies, one of which directed against the N-terminal portion of FGF23. The evaluation of the method accuracy involved the fully automated execution of a dilution test on EDTA plasma from 5 subjects who had not received any monoclonal antibody (mAb), 20 EDTA plasma from patients treated with Burosumab, and 2 EDTA plasma from subjects who had not received any mAb in witch an adequate volume of Burosumab had been added in vitro. One sample with specific diluent (LIAISON® FGF 23) with an adequate volume of Burosumab had been added in vitro. The dilution assay provided highly inaccurate iFGF23 results in samples with therapeutic concentrations of Burosumab and in samples with concentrations below the LoQ (6.5 pg/mL). The addition of Burosumab to the diluent did not produce any analytical interference. Dissociation of iFGF23 from the mAb-target complex in diluted sample could explain the loss of accuracy in the iFGF23 immunoassay using the Liaison XL analyzer. Burosumab could be an interferent in immunoassay procedures of iFGF23.</p>","PeriodicalId":15990,"journal":{"name":"Journal of immunoassay & immunochemistry","volume":" ","pages":"89-105"},"PeriodicalIF":0.0,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142567503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ahmed Shaker Elzantout, Amal Ahmed Mohamed, Manar Selim Fouda, Gamil Karam Mohamed, George Ghaly Girgis, Nesreen Hamdy Mahmoud, Mohamed Abdel Kader Elian, Mariana Victor Philips, Rasha Mohamed, Mohamed Moustafa Omran
{"title":"Evaluation of diagnostic performances of Pro-neurotensin and Heart-type fatty acid binding protein as reliable biomarkers for cardiovascular diseases.","authors":"Ahmed Shaker Elzantout, Amal Ahmed Mohamed, Manar Selim Fouda, Gamil Karam Mohamed, George Ghaly Girgis, Nesreen Hamdy Mahmoud, Mohamed Abdel Kader Elian, Mariana Victor Philips, Rasha Mohamed, Mohamed Moustafa Omran","doi":"10.1080/15321819.2024.2430332","DOIUrl":"10.1080/15321819.2024.2430332","url":null,"abstract":"<p><strong>Aim: </strong>In 2019, cardiovascular diseases accounted for 32% of global deaths. So, early detection of cardiac disorders is crucial. The study aimed to examine the suitability of Pro-neurotensin and Heart-type fatty acid binding protein as dependable biomarkers for cardiac patients with Heart failure as a primary diagnosis.</p><p><strong>Methodology: </strong>The prospective study involved 204 Egyptian volunteers (100 cardiac patients and 104 controls) enrolled from El-Sahel Teaching Hospital in Cairo, Egypt, between October 2022 and May 2023. Inclusion criteria included a high risk of cardiovascular events with symptoms like a fast or irregular pulse, shortness of breath, and fatigue. Exclusion criteria included asymptomatic individuals, cognitive disorders, and psychiatric conditions. The Research Ethics Committee approved the protocol. The consultant conducted a clinical examination of all patients and assessed their heart state. Serum ProNT and H-FABP were detected using a kit for the sandwich ELISA technique.</p><p><strong>Results: </strong>ProNT and H-FABP were significantly elevated in patients compared to controls with <i>p</i> < 0.001. Demonstrated sensitivity of 81% and 84%, with a specificity of 89% and 91%, respectively.</p><p><strong>Conclusion: </strong>Elevated ProNT and H-FABP levels are associated with severe CVDs, suggesting their potential as diagnostic biomarkers for patients, specifically those with heart failure, as a primary characteristic.</p>","PeriodicalId":15990,"journal":{"name":"Journal of immunoassay & immunochemistry","volume":" ","pages":"49-74"},"PeriodicalIF":0.0,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142729597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kazeem Sanjo Akinwande, Paul Akinniyi Akinduti, OlatunbosunGaniyu Arinola
{"title":"Rotavirus-specific-IgA and cytokines responses in <i>Ascaris lumbricoides-</i>infected preschool-aged Nigerian children following rotavirus vaccination.","authors":"Kazeem Sanjo Akinwande, Paul Akinniyi Akinduti, OlatunbosunGaniyu Arinola","doi":"10.1080/15321819.2024.2426147","DOIUrl":"10.1080/15321819.2024.2426147","url":null,"abstract":"<p><p>Rotavirus diarrhea and <i>Ascaris lumbricoides</i> (<i>Al</i>) infection increase intestinal morbidity and were associated with altered immune responses that compromise the vaccine efficacy in children. The serum level of rotavirus specific IgA (RV-IgA) and cytokine profiles in <i>A. lumbricoides</i> (<i>AI</i>) infected preschool-aged Nigerian children were estimated following oral rotavirus vaccination. Nineteen of the 149 preschool-aged children (aged 6 to 60 months) with <i>Ascaris lumbricoides</i> infection paired with age and sex-matched helminth - free children were administered with oral rotavirus vaccine after intestinal helminth screening using stool sample concentration technique. Separated sera from 3 mL venous blood samples were collected and estimated for cytokines (IFN-γ, TNF-α, IL-4, IL-8 IL-6, IL-10) and RV-IgA before and three weeks after rotavirus vaccination using Enzyme Linked Immunosorbent Assay. IFN-γ, IL-8, IL-4 were significantly lower at post-vaccination in <i>Al</i>-infected children compared with pre-vaccination. Serum IL-10 was significantly higher at post-vaccination in both <i>Al</i>-infected children and helminth-free controls, compared with pre-vaccination levels (<i>p</i> < 0.05). Pre-vaccination IL-8 and IL-6 were significantly higher in <i>Ascaris lumbricoides</i>-infected children, while the post-vaccination IL-8 was significantly higher in <i>Ascaris lumbricoides</i>-infected compared with control. At post-vaccination period, RV-IgA level was lower in <i>Al</i>-infected children and significantly higher in helminth - free control group compared to pre-vaccination RV-IgA level. <i>Ascaris lumbricoides</i> infection contributed to down-regulation of some cytokines and antibody responses to oral rotavirus vaccine.</p>","PeriodicalId":15990,"journal":{"name":"Journal of immunoassay & immunochemistry","volume":" ","pages":"75-88"},"PeriodicalIF":0.0,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142621868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A pilot study of interferon-induced helicase and glutamate decarboxylase gene polymorphism with autoimmune thyroid disease.","authors":"Sherin Sobhy Elnaidany, Abdlhamid Abdo Esmail, Enas Sobhy Zahran, Maram Fathi, Shimaa Kamal Zewain","doi":"10.1080/15321819.2024.2435856","DOIUrl":"10.1080/15321819.2024.2435856","url":null,"abstract":"<p><strong>Background: </strong>Numerous genes are involved in immune system modulation, and their polymorphisms may contribute to developing autoimmune disorders. Genetic variation contributes significantly to disease susceptibility to autoimmune thyroid disease (AITD).</p><p><strong>Objectives: </strong>This work aims to investigate the role of single-nucleotide polymorphisms (SNPs) of interferon induced with helicase C domain 1 (IFIH1) rs1990760 and glutamate decarboxylase (GAD) rs769404 in AITD development.</p><p><strong>Methods: </strong>The study had 330 participants, including 153 cases of Hashimoto's thyroiditis (HT), 77 cases of Graves' disease (GD), and 100 healthy controls. All subjects underwent medical history assessment and clinical evaluation. Tests were conducted using real-time PCR, including genotyping of IFIH1 (rs1990760) and GAD (rs769404) via an allele discrimination assay.</p><p><strong>Results: </strong>Most patients with AITD were females. About 18.3% of HT cases and 15.6% of GD cases have a positive family history of thyroid disease. A significant statistical difference was observed between AITD cases and control regarding IFIH1 (rs1990760) and GAD (rs769404) gene polymorphism. Moreover, GD patients, HT patients, and the control group showed increased CT and TT alleles in patients compared to those in controls.</p><p><strong>Conclusion: </strong>IFIH1 and GAD polymorphisms are involved in AITDs (HT and GD) development and are associated with some clinical presentations. HT and GD cases had a positive family history of thyroid disease. There was a significant statistical difference between AITD cases and control regarding IFIH1 (rs1990760) and GAD (rs769404) gene polymorphism.</p>","PeriodicalId":15990,"journal":{"name":"Journal of immunoassay & immunochemistry","volume":" ","pages":"106-121"},"PeriodicalIF":0.0,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142785797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eman A E Badr, Yostena Mekhail, Khaled S A Hassan, Mohamed F A Assar
{"title":"The role of SHMT2 and NDUFA4L2 gene expression and UCA1 levels in Egyptian patients with bladder cancer.","authors":"Eman A E Badr, Yostena Mekhail, Khaled S A Hassan, Mohamed F A Assar","doi":"10.1080/15321819.2025.2533800","DOIUrl":"10.1080/15321819.2025.2533800","url":null,"abstract":"<p><p>Bladder Cancer (BC) has a significant burden, with poor survival rates in advanced cases. This case-controlled study aimed to identify genes having diagnostic and prognostic value. Seventy patients with BC and 70 healthy individuals were included. Real-time PCR was used to quantify the expression of the <i>SHMT2</i> and <i>NDUFA4L2</i> genes, and <i>UCA1</i> levels. Results showed that <i>SHMT2, NDUFA4L2</i>, and <i>UCA1</i> were significantly upregulated in patients compared to the control group (<i>p</i> < 0.001). The area under the receiver operating characteristic curve (ROC) analysis showed that AUC was 0.995 (95% CI = 0.989-1, <i>p</i> < 0.001), 0.994 (95% CI = 0.987-1, <i>p</i> < 0.001) and 0.977 (95% CI = 0.958-0.996, <i>p</i> < 0.001) for <i>UCA1, SHMT2</i>, and <i>NDUFA4L2</i>, respectively with high diagnostic sensitivity and specificity. Additionally, the high expression of <i>SHMT2</i> and the high level of <i>UCA1</i> were correlated with histological grade (<i>p</i> < 0.001and 0.001, respectively) and with CT tumor size (p = 0.005 and 0.001, respectively). In univariate COX regression analysis, <i>SHMT2 and UCA1</i> were poor prognostic (p = 0.003 and 0.001, respectively). Furthermore, in the multivariate analysis, <i>UCA1</i> was independent poor prognostic factor (p =0.037). Thus, <i>SHMT2, NDUFA4L2</i>, and <i>UCA1</i> could be promising diagnostic and prognostic biomarkers and a novel therapeutic target.</p>","PeriodicalId":15990,"journal":{"name":"Journal of immunoassay & immunochemistry","volume":" ","pages":"435-449"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144637186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Albert Agyapong Tweneboah, Sherry Ama Mawuko Johnson, Patrick Mensah Amponsah, Derrick Adu Asare, Benjamin Obukowho Emikpe
{"title":"Seroprevalence and associated risk factors of Newcastle disease in guinea fowls in the Upper East region of Ghana.","authors":"Albert Agyapong Tweneboah, Sherry Ama Mawuko Johnson, Patrick Mensah Amponsah, Derrick Adu Asare, Benjamin Obukowho Emikpe","doi":"10.1080/15321819.2025.2518206","DOIUrl":"10.1080/15321819.2025.2518206","url":null,"abstract":"<p><p>Newcastle Disease (ND) is a major constraint to poultry production in sub-Saharan Africa. However, information on Newcastle disease in guinea fowls is scant in Ghana. This study seeks to detect circulating antibodies against ND and the risk factors for occurrence in guinea fowls in the Upper East region of Ghana. Sera was obtained from guinea fowls from households, live bird markets, and slaughter points in different locations in the Upper East region. The sera were evaluated for antibodies against Newcastle disease using the Haemagglutination Inhibition (HI) test. Questionnaire was administered to the farmers to assess risk factors such as vaccination status, management system, and contact with wild birds. Almost half, 213/431 (49.4%, 95% CI = 44.6-54.2) of the guinea fowls were seropositive. The seroprevalence was 46.2% in live bird markets, 36.63% in households, and 52.7% at slaughter points. A seroprevalence of 49.7% was observed in adults and 45.7% growers. There was a 53.4% prevalence in males and 43.9% in females. Antibodies to ND were found circulating in guinea fowls in the Upper East region. We recommend that guinea fowls be made an important component element in the ND surveillance for an effective monitoring and control in the region.</p>","PeriodicalId":15990,"journal":{"name":"Journal of immunoassay & immunochemistry","volume":" ","pages":"403-418"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144275099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"CXCR4 expression in immunohistochemistry of gastrointestinal neuroendocrine neoplasms: a meta-analysis.","authors":"Changlong Ruan, Jiajia Zhang, Yingying Liao, Yujie Hang, Yuan Dong, Hanfeng Shi, Xiaoya Wang","doi":"10.1080/15321819.2025.2482642","DOIUrl":"10.1080/15321819.2025.2482642","url":null,"abstract":"<p><strong>Objective: </strong>C-X-C chemokine receptor type 4 (CXCR4) is significantly associated with the development of various malignant tumors. This meta-analysis aims to investigate the expression of CXCR4 in the immunohistochemistry of gastrointestinal neuroendocrine neoplasms (GI-NENs).</p><p><strong>Methods: </strong>A comprehensive literature search regarding gastrointestinal neuroendocrine neoplasms and CXCR4 was conducted using PubMed,Web of Science, and the Cochrane Library, with a cut off date of June 30, 2024.Two researchers independently screened the literature according to inclusion and exclusion criteria and assessed study quality using the Newcastle-OttawaScale. Meta-analysis was performed using Stata version 17.0. The pooled positive rate was employed to evaluate the expression of CXCR4 in the immunohistochemistry of GI-NENs.</p><p><strong>Results: </strong>A total of eight studies involving 501 patients were included in this research. The immunohistochemical analysis revealed positive CXCR4 expression in 174 patients. The meta-analysis calculated and summarized the combined positive rate (R: 0.41; 95% CI = 0.21-0.60, <i>p</i> = 0.00), indicating that the differences were statistically significant.</p><p><strong>Conclusion: </strong>CXCR4 is highly expressed in the immunohistochemistry of GI-NENs, which may provide some evidence for the therapeutic application of CXCR4 antagonists in treating neuroendocrine neoplasms.</p>","PeriodicalId":15990,"journal":{"name":"Journal of immunoassay & immunochemistry","volume":" ","pages":"209-217"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143692395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}